These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 2167620)

  • 1. Vaccination against pseudorabies with glycoprotein gI+ or glycoprotein gI- vaccine.
    Vandeputte J; Chappuis G; Fargeaud D; Précausta P; Guillemin F; Brun A; Desmettre P; Stellmann C
    Am J Vet Res; 1990 Jul; 51(7):1100-6. PubMed ID: 2167620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High- and low-challenge exposure doses used to compare intranasal and intramuscular administration of pseudorabies virus vaccine in passively immune pigs.
    Arellano PE; Morrison RB; Molitor TW; Thawley DG
    J Am Vet Med Assoc; 1992 Mar; 200(5):685-91. PubMed ID: 1314793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV.
    Kit S; Kit M; McConnell S; Lawhorn B
    Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus.
    van Oirschot JT; Gielkens AL
    Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a pseudorabies virus vaccine based on deletion mutant strain 783 that does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Moormann RJ; Berns AJ; Gielkens AL
    Am J Vet Res; 1991 Jul; 52(7):1056-60. PubMed ID: 1654033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation in swine of a subunit vaccine against pseudorabies.
    Maes RK; Schutz JC
    Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs.
    van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT
    Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to glycoprotein I in maternally immune pigs exposed to a mildly virulent strain of pseudorabies virus.
    van Oirschot JT; Daus F; Kimman TG; van Zaane D
    Am J Vet Res; 1991 Nov; 52(11):1788-93. PubMed ID: 1664670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
    Mettenleiter TC; Klupp BG; Weiland F; Visser N
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constancy of Aujeszky's field virus antibody titres in sows repeatedly vaccinated with a gI-negative vaccine.
    Hopp W; Jungblut R
    Acta Vet Hung; 1994; 42(2-3):409-11. PubMed ID: 7810439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel concept for the control of Aujeszky's disease: experiences in two vaccinated pig herds.
    van Oirschot JT; Wijsmuller JM; de Waal CA; van Lith PM
    Vet Rec; 1990 Feb; 126(7):159-63. PubMed ID: 2155499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental infection of fattening pigs with pseudorabies (Aujeszky's disease) virus: efficacy of attenuated live- and inactivated-virus vaccines in pigs with or without passive immunity.
    Vannier P
    Am J Vet Res; 1985 Jul; 46(7):1498-502. PubMed ID: 2992327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1.
    Mikulska-Skupień E; Szweda W; Procajło Z
    Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a killed gpX deleted pseudorabies virus vaccine.
    Cook DR; Hill HT; Kinker DR
    Can J Vet Res; 1990 Oct; 54(4):438-45. PubMed ID: 2174294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure.
    Kelling CL; Staudinger WL; Rhodes MB
    Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spread of pseudorabies virus among breeding swine in quarantined herds.
    Duffy SJ; Morrison RB; Thawley DG
    J Am Vet Med Assoc; 1991 Jul; 199(1):61-5. PubMed ID: 1653189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A method for distinguishing infected from vaccinated pigs as a basis for the control of Aujeszky's disease].
    van Oirschot JT
    Tijdschr Diergeneeskd; 1988 Jan; 113(1):19-27. PubMed ID: 2829384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response of pigs to inactivated monovalent and bivalent vaccines for porcine parvovirus and pseudorabies virus.
    Mengeling WL; Gutekunst DE; Pirtle EC
    Am J Vet Res; 1980 Oct; 41(10):1569-71. PubMed ID: 6261613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus.
    Kit S; Kit M; Pirtle EC
    Am J Vet Res; 1985 Jun; 46(6):1359-67. PubMed ID: 2992322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Safety aspects of the practical application of a gI-negative subunit vaccine against Aujeszky's disease in swine].
    van Lom HB; Schrijver RS; Reynaud G; Schirvel C
    Tijdschr Diergeneeskd; 1990 Feb; 115(4):159-62. PubMed ID: 2154870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.